Rotate the device
Child-Proof Pharmaceutical Packaging: A Rapidly Evolving Market
In recent years, awareness around the safe storage and use of pharmaceutical products at home has grown exponentially.
According to data from the European Medicines Agency (EMA) and the World Health Organization (WHO), accidental ingestion of medicines by children remains one of the leading causes of unintentional pediatric hospitalization across Europe.
This growing concern has pushed the pharmaceutical packaging sector to evolve quickly toward child-proof solutions—closure systems specifically designed to be secure and resistant to unintended opening by children.
For companies specializing in the design and production of moulds, like Giurgola Stampi, this shift represents both a technical challenge and a significant strategic opportunity.
Between 2020 and 2024, global demand for child-resistant closures has grown at an estimated compound annual growth rate (CAGR) of 6–7%
(Statista – Pharmaceutical Packaging Report 2023).
The main growth drivers are:
Tighter regulations: EU Regulation 2017/745 (MDR) and Regulation 2019/1020 (Market Surveillance) have introduced stricter safety requirements for medical devices and pharmaceutical packaging.
Rise in OTC (Over the Counter) products: Increased availability of non-prescription drugs has driven the need for safer packaging solutions.
Preventive culture: Families are becoming more aware of domestic safety, encouraged by education campaigns led by organizations such as the WHO.
To meet these new standards, the design of moulds for capsules and child-proof closures must evolve to include:
Complex geometries: double-click, compression, and twist-lock systems that are secure yet ergonomic.
Stringent resistance testing: including both mechanical testing (sealing, torque) and chemical testing (resistance to pharmaceutical solvents).
Cycle time optimization: creating moulds that deliver high-precision results with excellent productivity and efficiency.
In this context, co-design—collaborative development between the mould maker and the client—becomes a key factor in meeting both regulatory and industrial production needs.
Giurgola Stampi has long positioned itself as a strategic partner to the pharmaceutical and medical sectors, offering:
High-precision moulds for caps, dosing devices, and child-resistant closures.
Tailored solutions, optimized for specific technical materials.
Integrated testing systems to simulate real-world safety performance before scaling up to production.
Our approach is focused on drastically reducing time-to-market while ensuring full compliance with international regulations.
The pharmaceutical packaging industry is clearly moving toward child-resistant solutions—not just to meet legal requirements, but also to take greater social responsibility for protecting vulnerable consumers.
At Giurgola Stampi, we see every project as an opportunity to innovate, improve safety, and strengthen the trust we build with our partners.
Get in touch with us to develop your next-generation, high-precision child-proof solution.